The MRP is similar to the Decentralised Procedure but with later involvement of the Concerned Member States in the assessment by the Reference Member State. The Coordination Group for Mutual Recognition and Decentralised Procedures provides guidance and acts to facilitate agreement among the participating states.
This module describes the roles of the various players in the procedure, the sequence and duration of the stages involved, and the requirements on content, format and timing of submissions. It discusses the special issues that apply to generic products in the MRP.
Who will benefit from this module?
This module is primarily aimed at regulatory affairs professionals dealing with marketing authorisation applications and related submissions for regulatory approval in Europe. More generally, it will also be of interest to all those involved in the development and registration of medicinal products.
- Provide an overview of the MRP process.
- Describe the pre-submission and submission actions in relation to timeline deadlines.
- Specify the responsibilities of the Reference Member State (RMS), the Concerned Member States (CMSs) and the applicant.
CPD Points: 2
Assessment: Multiple-choice mastery assessment
The MRP process - This session takes you through the entire process from initial national authorisation by the RMS to the issuing of national licences by the CMSs. Referral of issues to the CMD, and the arbitration process, are also covered.
Generics and the MRP - This session gives a brief introduction to generics and the special issues that apply to generic products in the MRP.